The role of natural killer T cells in costimulation blockade-based mixed chimerism

Transplant International

Volumn 23, Issue 11, 2010, Pages 1179-1189

  Nierlich, Patrick Nikolaus ^a   Klaus, Christoph ^a   Bigenzahn, Sinda ^a   Pilat, Nina ^a   Koporc, Zvonimir ^a   Pree, Ines ^a   Baranyi, Ulrike ^a   Taniguchi, Masaru ^b   Muehlbacher, Ferdinand ^a   Wekerle, Thomas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Institute of Physical and Chemical Research   (Japan)

Author keywords

costimulation blockade; mixed chimerism; natural killer T cells; tolerance

Indexed keywords

ALPHA GALACTOSYLCERAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL FUNCTION; CHIMERA; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; T CELL DEPLETION; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; CHIMERISM; FEMALE; GALACTOSYLCERAMIDES; IMMUNE SYSTEM; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; KILLER CELLS, NATURAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; SKIN TRANSPLANTATION; T-LYMPHOCYTES; WHOLE-BODY IRRADIATION;

EID: 77957588618     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01120.x     Document Type: Article

References (54)

1. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008 358 : 353.
2. Scandling JD, Busque S, Dejbakhsh-Jones S, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008 358 : 362.
3. Fehr T, Sykes M. Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl Int 2008 21 : 1118.
4. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen. J Exp Med 1989 169 : 493.
5. Tomita Y, Sachs DH, Khan A, Sykes M. Additional mAb injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mAbs and 3 Gy whole body irradiation. Transplantation 1996 61 : 469.
6. Higuchi M, Zeng D, Shizuru J, et al. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J Immunol 2002 169 : 5564.
7. Wekerle T, Nikolic B, Pearson DA, Swenson KG, Sykes M. Minimal conditioning required in a murine model of T cell depletion, thymic irradiation and high-dose bone marrow transplantation for the induction of mixed chimerism and tolerance. Transpl Int 2002 15 : 248.
8. Wekerle T, Sayegh MH, Hill J, et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998 187 : 2037.
9. Adams AB, Durham MM, Kean L, et al. Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. J Immunol 2001 167 : 1103.
10. Taylor PA, Lees CJ, Waldmann H, Noelle RJ, Blazar BR. Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions. Blood 2001 98 : 467.
11. Wekerle T, Blaha P, Langer F, Schmid M, Muehlbacher F. Tolerance through bone marrow transplantation with costimulation blockade. Transpl Immunol 2002 9 : 125.
12. Bigenzahn S, Blaha P, Koporc Z, et al. The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. Am J Transplant 2005 5 : 1237.
13. Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 2002 14 : 592.
14. Wekerle T, Kurtz J, Ito H, et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nature Med 2000 6 : 464.
15. Durham MM, Bingaman AW, Adams AB, et al. Administration of anti-CD40 ligand and donor bone marrow leads to hematopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol 2000 165 : 1.
16. Blaha P, Bigenzahn S, Koporc Z, et al. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 2003 101 : 2886.
17. Westerhuis G, Maas WGE, Willemze R, Toes REM, Fibbe WE. Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance. Blood 2005 106 : 2215.
18. Kean LS, Hamby K, Koehn B, et al. NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation. Am J Transplant 2006 6 : 292.
19. Iwai T, Tomita Y, Okano S, et al. Regulatory roles of NKT cells in the induction and maintenance of cyclophosphamide-induced tolerance. J Immunol 2006 177 : 8400.
20. Pillai A, George T, Dutt S, Strober S. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+ CD25+ Foxp3+ T regulatory cells that protects against graft-versus-host disease. Blood 2009 113 : 4458.
21. Kuns RD, Morris ES, MacDonald KPA, et al. Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administration. Blood 2009 113 : 5999.
22. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004 114 : 1379.
23. Zhou D, Mattner J, Cantu C III., et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 2004 306 : 1786.
24. Tyznik AJ, Tupin E, Nagarajan NA, Her MJ, Benedict CA, Kronenberg M. Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J Immunol 2008 181 : 4452.
25. Mattner J, DeBord K, Ismail N, et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 2005 434 : 525.
26. Kinjo Y, Tupin E, Wu D, et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 2006 7 : 978.
27. Sharif S, Arreaza GA, Zucker P, et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001 7 : 1057.
28. Singh AK, Wilson MT, Hong S, et al. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 2001 194 : 1801.
29. Hong C, Park SH. Application of natural killer T cells in antitumor immunotherapy. Crit Rev Immunol 2007 27 : 511.
30. Kim HY, Kim HJ, Min HS, et al. NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production. J Exp Med 2005 201 : 41.
31. Tupin E, Nicoletti A, Elhage R, et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 2004 199 : 417.
32. Seino KI, Fukao K, Muramoto K, et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci USA 2001 98 : 2577.
33. Ikehara Y, Yasunami Y, Kodama S, et al. CD4+ V14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J Clin Invest 2000 105 : 1761.
34. Sonoda K-H, Taniguchi M, Stein-Streilein J. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J Immunol 2002 168 : 2028.
35. Kiyomoto T, Ito T, Uchikoshi F, et al. The potent role of graft-derived NKR-P1 + TCR+ () cells in the spontaneous acceptance of rat liver allografts. Transplantation 2005 80 : 1749.
36. Toyofuku A, Yasunami Y, Nabeyama K, et al. Natural killer T-cells participate in rejection of islet allografts in the liver of mice. Diabetes 2006 55 : 34.
37. Patterson S, Kotsianidis I, Almeida A, et al. Human invariant NKT cells are required for effective in vitro alloresponses. J Immunol 2005 175 : 5087.
38. Jukes J, Wood K, Jones N. Natural killer T cells: a bridge to tolerance or a pathway to rejection? Transplantation 2007 84 : 679.
39. Pratschke J, Stauch D, Kotsch K. Role of NK and NKT cells in solid organ transplantation. Transpl Int 2009 22 : 859.
40. Cui J, Shin T, Kawano T, et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 1997 278 : 1623.
41. Pree I, Bigenzahn S, Fuchs D, et al. CTLA4Ig promotes the induction of hematopoietic chimerism and tolerance independently of indoleamine-2,3- dioxygenase (IDO). Transplantation 2007 83 : 663.
42. Trambley J, Bingaman AW, Lin A, et al. Asialo GM1(+) CD8 (+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999 104 : 1715.
43. Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997 278 : 1626.
44. Kawano T, Cui J, Koezuka Y, et al. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. Proc Natl Acad Sci USA 1998 95 : 5690.
45. Nishimura T, Kitamura H, Iwakabe K, et al. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol 2000 12 : 987.
46. Carnaud C, Lee D, Donnars O, et al. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 1999 163 : 4647.
47. Smyth MJ, Crowe NY, Godfrey DI. NK cells and NKT cells collaborate in host protection from methylcholantrene-induced fibrosarcoma. Int Immunol 2001 13 : 459.
48. Haraguchi K, Takahashi T, Matsumoto A, et al. Host-residual invariant NK T cells attenuate graft-versus-host immunity. J Immunol 2005 175 : 1320.
49. Pilat N, Klaus C, Schwaiger E, Wekerle T. Hurdles to the induction of tolerogenic mixed chimerism. Transplantation 2009 87 : S79.
50. + cells. Am J Transplant 2001 1 : 339.
51. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F1 hybrid mice. J Exp Med 1971 134 : 1513.
52. Williams MA, Tan JT, Adams AB, et al. Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance. J Immunol 2001 167 : 4987.
53. Kajiwara T, Tomita Y, Okano S, et al. Effects of cyclosporin A on the activation of natural killer T cells induced by -galactosylceramide. Transplantation 2007 83 : 184.
54. Dalle J, Dardari R, Menezes J, Cordeiro P, Champagne M, Duval M. Binding of thymoglobulin to natural killer cells leads to cell activation and interferon-gamma production. Transplantation 2009 87 : 473.